Nuzenio

Stat Silence Therapeutics

Stat Silence Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 20:19:00 GMTRecon: BMS plans $2.3B Houston manufacturing site; MHRA approves Lilly weight-loss drug for weight loss, type 2 diabetes - RAPS
Mon, 10 Aug 2026 15:34:15 GMTSionna’s experimental cystic fibrosis pill falls flat in mid-stage trial - STAT
Mon, 10 Aug 2026 14:49:08 GMTFDA panel to weigh Grail’s Galleri test - STAT
Mon, 10 Aug 2026 11:43:53 GMTHeart failure drug from Tenax Therapeutics fails in pivotal study - STAT
Mon, 10 Aug 2026 11:33:33 GMTSilence Therapeutics aims at Takeda with new data in rare blood cancer - STAT
Mon, 10 Aug 2026 11:26:59 GMTSilence Therapeutics (SLN) halves losses and funds operations into 2028 in Q2 update - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Stat Silence Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.